Hutchin Hill Capital’s St Jude Medical STJ Stock Holding History

Hutchin Hill Capital’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-93,400	Closed	-$5.77M	–	878
2015 Q4	$5.77M	Buy	+93,400	New	+$5.89M	0.14%	118
2015 Q2	–	Sell	-84,000	Closed	-$5.49M	–	908
2015 Q1	$5.49M	Buy	+84,000	New	+$5.59M	0.15%	136

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Hutchin Hill Capital's STJ Position: Q1 2016 in Review

Hutchin Hill Capital sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 93,400 shares — an estimated $5.77M sold.

Hutchin Hill Capital first reported a position in STJ in Q1 2015 and held it in 2 quarters. The position peaked at $5.77M in Q4 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

Hutchin Hill Capital reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
Hutchin Hill Capital sold 93,400 St Jude Medical shares in Q1 2016, an estimated $5.77M.
Hutchin Hill Capital first reported a position in St Jude Medical in Q1 2015 and held it in 2 quarters.
Hutchin Hill Capital's St Jude Medical position peaked at $5.77M in Q4 2015.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Hutchin Hill Capital's 13F filing for Q1 2016, filed 16 May 2016.